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Low Specificity of the Bacterial Index for the Diagnosis 
of Bacterial Pneumonia by Bronchoalveolar Lavage 
R. Speich, M. Hauser, T. Hess, J. Wrist, E. Grebski, F. H. Kayser, E. W. Russi 
Abstract The bacterial index (BI) as defined by the sum of log~o colony-forming 
units (cfu) of microorganisms per milliliter of bronchoalveolar lavage (BAL) fluid, 
i.e., a multiplication of the single cfu/ml, has been used to distinguish between poly- 
microbial pneumonia (BI___5) and colonization (BI<5). Since many false-positive 
results are to be expected using this parameter, the diagnostic value of the BI was 
studied prospectively by obtaining bacteriologic cultures of BAL fluid in 165 conse- 
cutive unselected patients. In 27 cases the diagnosis of bacterial pneumonia was es- 
tablished on clinical criteria. In 133 patients pneumonia could be excluded, and in 
five patients the diagnosis remained unclear. Using a cut-off of _> 10 s cfu/ml BAL 
fluid, sensitivity and specificity for the diagnosis of pneumonia were 33% (9/27) and 
99% (132/133), respectively. Sensitivity was mainly influenced by prior treatment 
with antibiotics, being 70% (7/10) in untreated and 12% (2/17) in treated patients, 
Applying the BI methodology at a cut-off of _ 5, however, resulted in an unaccept- 
ably high rate of 16 additional false-positive results, thus lowering the specificity to 
87% (116/133; P<0.0001) while increasing the sensitivity to only 41% (11/27; 
P = 0.77). In conclusion, given the high rate of false-positive r sults, the methodology 
of the BI is of doubtful value for the diagnosis of bacterial pneumonia by BAL in an 
unselected patient group. By applying the absolute number of cfu/ml BAL fluid, 
however, positive bacteriologic cultures of BAL fluid are highly specific for the diag- 
nosis of pneumonia. Their sensitivity is limited by previous antibiotic therapy. 
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Introduction 
The diagnosis of bacterial pneumonia remains difficult. 
Clinical findings such as fever, physical exam, leuko- 
cytosis, or abnormal chest radiographs are often non- 
specific or even misleading, especially in the ventilated 
patient [1]. Microscopic examination and cultures of spu- 
tum or tracheobronchial secretions retrieved by aspira- 
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tion or bronchoscopy are nonspecific due to contam- 
ination by flora from the upper respiratory tract [2], 
Transtracheal aspirates also do not allow differentia- 
tion between infection and colonization of the lower 
respiratory tract, especially in patients with chronic 
bronchitis [3]. Furthermore, transtracheal aspiration 
cannot be performed in mechanically ventilated pa- 
tients. 
During recent years the reliability of bronchoalveolar 
lavage (BAL) for the diagnosis of bacterial pneumonia 
has been studied intensively. Kahn and Jones [4] and 
Thorpe et al. [5] have demonstrated that quantitative 
bacterial cultures of BAL fluid from nonventilated pa- 
tients allow differentiation between colonization and 
infection of the lower respiratory tract at a cut-off of 
10 s colony-forming units (cfu) per milliliter of BAL 
fluid. The sensitivity for detecting bacterial pneumonia 
was reported to range from 87-100%, with specificity 
79 
ranging from 70-100% [4, 5]. The importance of BAL  
for the early recognit ion of venti lator-associated bacte- 
rial pneumonia  has also been documented [6, 7]. 
Lately, innovative techniques of performing BAL ,  such 
as nonbronchoscopic  "blind" [8, 9] and protected BAL  
[10], have been described. Furthermore,  we have re- 
cently evaluated a novel bedside technique for quanti- 
tative cultures of BAL  fluid using dip slides [11]. These 
methods will presumably propagate the use of BAL  as 
an important diagnostic tool [12-17]. 
To account for the fact that nosocomial  pneumonia  is 
often due to polymicrobial  infection, Johanson et al. [6] 
proposed the calculation of  a so-called bacterial index 
(BI) by adding up the loglo converted numbers of colo- 
ny-forming units of individual organisms per BAL  spe- 
cimen. For instance, a BI  of 6 may represent a single 
organism in a concentrat ion of 106 cfu/ml BAL  fluid or 
may stand for the detection of three different species, 
each at a concentrat ion of 102 cfu/ml BAL  fluid. Since a 
BI  of __ 5 is considered sensitive and specific for the di- 
agnosis of a lower respiratory tract infection [6, 9], low 
concentrations of several bacterial strains would erron- 
eously suggest he diagnosis of pneumonia.  We believe 
the concept of the BI to lack a sound microbiological 
basis. Moreover,  according to our experience, the use 
of the BI  reduces the specificity of BAL  in the diagno- 
sis of bacterial pneumonia.  Therefore,  we decided to 
study prospectively the diagnostic value of the BI  as in- 
troduced by Johanson et al. [6] and used by others [8, 9] 
compared to the absolute number  of the cfu/ml BAL  
fluid in an unselected patient group undergoing bron- 
choscopy for a variety of indications. 
Patients and Methods 
Patients. One hundred sixty-five patients (mean age, 45 years; 
range, 18-77 years; 55 women, 110 men) consecutively underwent 
flberoptic bronchoscopy with BAL for the following indications: 
evaluation of pulmonary complications during immunosuppres- 
sion (54 HIV-infected patients, 27 patients after solid organ trans- 
plantation, 18 patients with hematologic malignancies), suspected 
pneumonia in non-immunosuppressed patients (n =33), bilateral 
infiltrative lung disease of unknown origin (n = 22), and suspected 
bronchogenic carcinoma (n=11). Eight patients were lavaged 
twice, and each BAL was considered separately. Nine patients 
were intubated and mechanically ventilated, and 59 patients were 
treated with antibiotics prior to bronchoscopy. 
Bronchoalveolar Lavage. The fiberoptic bronchoscope (Olym- 
pus type; Olympus Opticals, Switzerland) was inserted through a 
nostril in nonintubated patients and through an endotracheal 
tube via a sterile swivel adaptor (single-use 15 mm swivel adaptor; 
Portex, Hythe, UK) in ventilated patients. Nonintubated patients 
received 0.5 mg of atropine sulfate 15 rain before bronchoscopy. 
Intravenously administered hydrocodone 7.5-15 mg and flunitra- 
zepam 1-2 mg were used for additional sedation. The patients 
received 5-10 ml of nebulized 4% Iidocaine with 10 drops of sal- 
butamol followed by 10 ml of 1% lidocaine injected through the 
bronchoscope onto the vocal cords. Suctioning through the bron- 
choscope channel and injecting lidocaine onto the airways was 
avoided whenever possible. During the examination the patients 
were given supplemental oxygen 2-6 l/rain through the unused 
nostril or a face mask. Intubated patients received additional se- 
dation with midazolam and morphine sulfate intravenously as re- 
quired. Before BAL was started, the ventilator settings were 
changed. The FIO2 was switched to 1.0 and the tidal volume was 
increased by 20%. The oxygen saturation was monitored by a 
transcutaneous pulse oximeter (Ohmeda Biox 3740 Pulse Oxi- 
meter; Ohmeda, USA) through afinger probe. The bronchoscope 
tip was wedged into the subsegmental bronchus leading to the 
area showing the most prominent infiltrations on the chest radio- 
graph. Four 50 ml aliquots of sterile isotonic saline were injected 
then gently hand-aspirated with a syringe. The recovery ranged 
from 40-80%. The BAL fluid was filtered through a double layer 
of sterile surgical gauze and pooled into a sterile graduate cylin- 
der. The BAL samples were immediately submitted for microbio- 
logic analysis. 
Bacteriology. The quantitative bacterial cultures of the pooled 
BAL fluid were performed by plating 0.001 ml of the original spe- 
cimen with a calibrated loop according to a widely accepted 
standard [18] onto sheep blood agar, chocolate agar, CNA agar 
(blood agar containing colistin and nalixidic acid), and MacCon- 
key agar. After inoculation the plates were incubated at 37 ~ in 
5% CO2; MacConkey agar was incubated aerobically without 
CO2. Culture plates were examined for growth after 24 and 48 h. 
Colonies with distinct morphologies were enumerated separately 
and the results were expressed as cfu/mI BAL fluid. Identification 
of organisms was performed according to standard recommenda- 
tions [19]. The BI was calculated according to Johanson et al. [6] 
for each of the BAL specimens by adding up the log10 of the con- 
centrations of the individual organisms per BAL specimen. A val- 
ue of _>5 was considered iagnostic for bacterial pneumonia [6, 
9]. Furthermore, the absolute number of cfu/ml BAL fluid of the 
single microorganisms and the sum of cfu/ml per BAL sample 
were calculated for each patient, and a value _> 105 was consid- 
ered diagnostic for pneumonia [4, 5]. 
Clinical Variables. Bacterial pneumonia was diagnosed clinically 
if all of the following criteria were present: (i) fever >38.5 ~ or 
purulence of tracheobronchial secretions; (ii) a new or progres- 
sive localized infiltrate on chest radiographs; and (iii) improve- 
ment after adequate antimicrobial therapy. The diagnosis of 
pneumonia s well as the alternative diagnosis in the nonpneu- 
monia cases was made prospectively by the treating physicians, 
independent of the study team. The quantitative cultures were 
performed for the study purposes only. 
Statistical Analysis. Frequencies and categories were compared 
with the use of Fisher's exact est. A P value of < 0.05 was consid- 
ered significant. Sensitivity and specificity were calculated accord- 
ing to standard formulas. Confidence intervals (CI) of 95% were 
calculated by standard methods [20]. The performance of the di- 
agnostic tests was determined by a receiver operating characteris- 
tic (ROC) curve analysis according to the recommendations of 
Hanley and McNeil [21]. Briefly, sensitivity and 1 - specificity are 
plotted at multiple cut points, and a curve is generated. The area 
under the curve (AUC) represents he diagnostic performance of
the test relative to the diagnostic performance of a hypothetical 
perfect test (100% specificity; 100% sensitivity; AUC 1.0). By 
comparing the AUC of the various tests, it is possible to judge the 
performance of the tests as a diagnostic and screening tool. Most 
clinically useful diagnostic tests have an AUC of 0.8-0.9. 
Results 
In 27 of the 165 patients (16.4%), the diagnosis of bac- 
terial pneumonia  was established according to clinical 
criteria. These criteria were not fulfilled in 133 cases 
(80.6%), and an alternative diagnosis was made in most 
instances: sepsis or fever of unknown origin with nor- 
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mal chest radiograph (n=19); Pneumocystis carinii 
pneumonia in HIV-infected (n = 12) and non-HIV im- 
munosuppressed patients (n = 12); nonspecific intersti- 
tial pneumonia not treated with antibiotics (n=12); 
vasculitis with pulmonary alveolar hemorrhage (n = 8); 
pulmonary tuberculosis (n =7); pulmonary lymphoma 
(n =7) and other neoplasias (n = 8); sarcoidosis (n = 6); 
mucus plugging (n = 5); bronchiolitis obliterans (n = 4); 
pulmonary embolism (n =4); left heart failure (n =3); 
eosinophilic pneumonia (n =2); pneumonia due to As- 
pergillus fumigatus (n=6), Legionella pneumophila 
(n=3), cytomegalovirus (n=3), Nocardia asteroides 
(n = 2), Cryptococcus neoformans (n = 2), or MycopIas- 
ma pneumoniae (n=l) ;  herpetic tracheobronchitis 
(n=l) ;  chemotherapy-induced lung diseases (n=2); 
and chronic bronchitis with normal chest radiography 
(n = 3). Five patients (3%) were lost to follow-up. They 
were excluded from further analysis. 
The distribution of the colony counts per milliliter of 
BAL fluid in patients with and without pneumonia, re- 
spectively, is shown in Figure 1A. In nine of the 27 pa- 
tients with pneumonia, t least one bacterial strain at a 
count of _> 105 cfu/ml BAL fluid was detected: Haerno- 
philus influenzae (n=5), Pseudornonas aeruginosa 
(n=2), and viridans streptococci (n =2). Only in one 
patient without pneumonia (Table 1, case 17) was 
Streptococcus pneumoniae at a concentration of _> 105 
cfu/ml BAL fluid found. Thus, with regard to pneu- 
monia diagnosed by clinical criteria (see Methods), a 
threshold of 105 cfu/ml BAL fluid resulted in a sensitiv- 
ity of 33% (9/27; CI, 23-57%) and a specificity of 99% 
(132/133; C1, 98-100%). Lowering the cut-off point to 
10 4 cfu/ml BAL fluid increased the sensitivity to 59% 
(16/27; C1, 49-84%; not significant compared to a cut- 
off point of 105 cfu/ml, P=0.10) but significantly re- 
duced the specificity to 82% (108/133; C1, 77-90%; 
P<0.0001). Due to low case numbers, an analysis of 
the various subgroups of underlying diseases was possi- 
ble only in the 54 HIV-infected patients. Using the cri- 
teria mentioned above, the sensitivity of BAL with re- 
gard to pneumonia was 36% (4/11; CI, 27-54%; not sig- 
nificant compared to the non-HIV group), and the spe- 
cificity was 100% (43/43). 
The low sensitivity of BAL for the diagnosis of bacteri- 
al pneumonia in our study population with a relatively 
low prevalence of pneumonia was mainly due to antim- 
icrobial pretreatment. This important issue is illustrated 
by the distribution of the colony counts per milliliter of 
BAL fluid in patients with and without pneumonia, re- 
spectively, who had not been trea(ed previously with 
antibiotics (Figure 1B) compared to those who had 
been receiving antimicrobial agents before BAL (Fig- 
ure 1C). In patients without antibiotics prior to BAL, 
the sensitivity for the diagnosis of pneumonia improved 
to 70% (7/10; C1, 64-100%; P=0.067 compared to all 
patients; P = 0.0037 compared to those pretreated with 
antibiotics), and the specificity remained at 99% (94/95; 
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Figure I Distribution ofthe sum of cfu/ml BAL fluid in individu- 
al patients with and without bacterial pneumonia, considering A 
all patients, B patients not receiving antibiotics before BAL, and 
C patients treated with antibiotics atthe time of BAL 
C1, 98-100%). In contrast, compared to the patients not 
pretreated with antibiotics, the sensitivity was signifi- 
cantly reduced to 12% (2/17; CI, 8-39%; P=0.0037) in 
patients receiving antibiotics at the time of BAL. Low- 
ering the cut-off point in this patient group to 104 cfu/ 
ml BAL fluid increased the sensitivity to 35% (6/17; C1, 
26-67%; NS, P=0.22) but decreased the specificity 
from 100% (38/38; C1, 100-100%) to 92% (35/38; C1 
88-100%; NS, P=0.24). 
When a BI of _>5 was taken as a diagnostic riterion 
for bacterial pneumonia, two further true-positive re- 
sults were obtained (sensitivity 41%; C1, 31-66%; 
P=0.77 compared to the sensitivity of the absolute 
number of organisms at a cut-off point of 105 cfu/ml 
BAL fluid). The use of the BI, however, resulted in 16 
additional false-positive diagnoses. Therefore, specifici- 
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Table 1 Characteristics of patients without bacterial pneumonia exhibiting a bacterial index of -5  
Patient Age/ Underlying condition(s); radiographic findings; Previous 
no. sex diagnosis antibiotic 
therapy 
Organisms cultured from BAL 
fluid (cfu/ml BAL fluid) 
Bacterial 
index 
1 39m a 
2 29m a 
3 36m 
34m 
43f 
6 35f 
7 34m 
8 29m 
9 52m 
10 67m 
11 38m 
[2 36m 
13 35m 
14 20f 
15 18f d 
16 52m 
17 33m e 
HIV infection, acute bronchitis; normal chest no 
radiograph; HIV-associated fever 
HIV infection, herpetic tracheobronchitis; yes 
normal chest radiograph 
HIV infection, chronic bronchitis; normal chest no 
radiograph; evaluation for suspected PCP 
negative 
asymptomatic; normal chest radiograph; evalua- no 
tion for hilar lymphadenopathy unremarkable 
HIV infection, chronic bronchitis; normal chest no 
radiograph; evaluation for suspected PCP nega- 
tive 
CMV infection after kidney transplantation; no 
normal chest radiograph 
pulmonary tuberculosis; only mild interstitial no 
LUL changes on chest radiograph and CT scan 
HIV and disseminated Mycobacteriurn simiae no 
infection; subtle increased interstitial markings 
on chest radiograph; evaluation for suspected 
PCP negative 
HIV infection, nonspecific interstitial pneumo- no 
nitis; subtle increased interstitial markings on 
chest radiograph 
HIV infection, PCP; subtle increased interstitial no 
markings on chest radiograph 
HIV infection, PCP; subtle increased interstitial no 
markings on chest radiograph 
HIV infection, PCP; subtle increased interstitiaI yes 
markings on chest radiograph 
psoriasis vulgaris, chronic bronchitis; subtle no 
chronic interstitial markings on chest radio- 
graph 
non-Hodgkin's lymphoma; bilateral interstitial no 
infiltrates; suspected cytotoxic agent-induced 
pneumonitis, improvement after corticosteroid 
treatment 
severe renal failure after meningococcal sepsis, no 
fluid overload; bilateral acinar shadows; im- 
provement within i day, no antibiotic therapy 
asymptomatic chronically scarred LUL infil- no 
trates; superinfecti0n with Mycobacterium 
xenopi 
HIV infection, bronchitiS; normal chest radio- no 
graph 
viridans streptococci (2x 104), 
Candica albicans (5 x 103) 
normal oral flora c (1.8 x 104), 
C. albicans (2 x 103) 
normal oral flora (6 x 103), 
Haemophilus influenzae 
(5 x 103), C. albicans (104) 
Streptococcus pneumoniae 103), 
normal oral flora (103 )
viridans streptococci (2 x 103), 
H. influenzae (103) 
8.0 (4.3) u 
7.6 (4.3) u 
11,5 (7.5) b 
6,0 
6.3 
H. influenzae (103), normal oral 7.3 
flora (2 x 10 4) 
normal oral flora (1.4 x 104), H, 7.4 
influenzae (2 x 103) 
Streptococcus pneumoniae 10.9 
(4 x 104), Staphylococcus aureus 
(2 x 103), viridans streptococci 
(103 )
Staphyloccocus aureus 8.1 
(1.4 x 104), normal oral flora 
(1o 4 ) 
Staphylococcus aureus (2 x }O3), 6.6 
viridans streptococci (2x 10 ") 
Streptococcus pneumoniae 7.9 
(2.4 x 104), Staphylococcus epi- 
dermidis (3 x 103) 
H. influenza (103), normal oral 6.6 
flora (4 x 103) 
Streptococcus pneumoniae 7.9 
(5 x 103), H. influenzae 
(1.5 x 104) 
Pseudornonas eruginosa 9.2 
(6 • 104), viridans streptococci 
(2.3 x 104) 
Staphylococcus aureus 6.2 
(1.2 x 103), Xanthomonas malto- 
phila (1.2 x 103) 
viridans streptococci 3(.7 x 104), 12.1 
H. influenzae (2 x 10 ), Strepto- 
coccus pneumoniae (1.1 x 104) 
Streptococcus pneumoniae (106) 6.0 
a Patients with a bacterial index of <5, if C. albicans isnot con- 
sidered 
b Values of bacterial index without consideration 'of C. albicans 
are shown in parentheses : . . . .  , 
c Normal oral flora defined as the growt h' of two or~ mo're of'the 
following bacteria: viridans streptococci'; Neisseria spp., coryne- 
forms, coagulase-negative staphylococci' .. . . :  , 
ty was significantly reduced from 99 to 87% (116/133; 
C1, 83-94%; P<0.0001) .  The clinical dat'a of the pa- 
tients without pneumonia  nd with a BI  Of _> 5 are dis- 
played in Table 1 (Table 1, patients 1-17). 
The performance of the different diagnostic parameters 
is il lustrated by the AUC of the ROC curve (Figure 2). 
Whereas the AUC for the BI  was only 0.674, the AUC 
of the sum of the cfu/mt BAL  fluid per patient reached 
d Mechanically ventilated patient 
Patient with a bacterial index of -> 5 and an absolute number of 
cfu/ml BAL fluid of _ 105 
CMV, cytomegalovirus; CT, computed tomography; HIV, human 
immunodeficiency virus; LUL, left upper lobe; PCP, Pneumocys- 
tis carinii pneumonia 
0.879. The AUC of the sum of cfu/ml BAL  fluid includ- 
ing only patients without previous antibiotic treatment 
was 0.99. 
Some authors even include the colony counts of fungal 
species in their calculations [8, 9]. However,  this might 
not have a sound basis, since there is no evidence of the 
diagnostic utility of quantitative fungal cultures. There 
were two patients in our group (Table 1, patients 1 and 
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Figure 2 Receiver operating characteristic (ROC) curve for the 
bacterial index (AUC=0.674) for the sum of cfu/ml BAL fluid, 
including all patients (AUC=0.879) and considering only pa- 
tients not treated with antibiotics at the time of BAL 
(AUC=0.99) 
2) in whom the BI was lower than 5 when the fungal 
colony counts were not included. However, even by ex- 
cluding these two cases, the specificity of a BI of >_5 
remained low at 89% (118/133; C1, 85-96%). 
Discussion 
The principal finding of this study is that using the BI at 
a cut-off of _> 5 in an unselected patient group with a 
relatively low prevalence of pneumonia (16.4%) results 
in an inacceptably low specificity for the diagnosis of 
bacterial pneumonia. Using the concept of the BI, 
which is calculated by adding up the loglo of the con- 
centrations of the individual organisms per milliliter of 
BAL specimen (i.e., multiplying the numbers of colony- 
forming units of individual organisms per milliliter of 
BAL specimen), resulted in 17 false-positive results in 
patients who decisively did not suffer from bacterial 
pneumonia (Table 1). All these patients except case 17 
(Streptococcus pneumoniae, 10 6 cfu/ml BAL fluid) 
would never have been diagnosed as having pneumonia 
if the absolute number of organisms at a cut-off of 105 
cfu/ml BAL fluid had been used. Hence, by applying 
the BI methodology, the superb specificity of BAL for 
the diagnosis of bacterial pneumonia was significantly 
reduced from 99-87% (P< 0.0001). The very low 
power of diagnostic discrimination of the BI is illus- 
trated by the small AUC in the ROC analysis (Figure 
2). 
The BI was introduced by Johanson et al. [6], who used 
it in a baboon model of nosocomial pneumonia. They 
demonstrated a very good correlation of the BI of BAL 
fluid compared to the BI of quantitative lung tissue cul- 
tures. The BI was created with the attempt o let spe- 
cies present only in small numbers contribute to an es- 
timation of the lungs' bacterial burden, especially dur- 
ing prolonged mechanical ventilation [6], The hypothe- 
sis behind the BI was that the presence of multiple spe- 
cies in low concentrations indicated a marked impair- 
ment in host defenses, a hypothesis that is still unprov- 
en and basically untested. However, the study of Johan- 
son et al. [6] became a landmark paper leading to a 
widespread use of quantitative bacterial cultures of 
BAL fluid for the diagnosis of bacterial nosocomial 
pneumonia [10, 15, 22]. Unfortunately, the BI was used 
rather uncritically by some subsequent authors [8, 91, 
while others relied on the absolute count of cfu/ml 
BAL fluid per single microorganism or the sum of cfu/ 
ml per BAL specimen at the cut-off point of 105 as an 
indicator for pneumonia [4, 5, 10, 15, 161. 
According to our findings, the concept of the BI, calcu- 
lated by adding up the log~0 cfu/ml BAL fluid of the 
individual microbial species per patient, thus multiply- 
ing the number of cfu/ml of different organisms, has no 
sound microbiological basis. In such a way, the pres- 
ence of very low concentrations of several different co- 
lonizing bacteria in an individual patient might lead to 
a BI of >5. In particular, this may occur in immunosup- 
pressed patients (such as in 12 of our study group, Ta- 
ble 1). Why the lungs of these patients contain quite 
high bacterial burdens is of great interest and should be 
studied further. Although our series included mainly 
nonventilated patients, we believe that our findings 
also apply to intubated and mechanically ventilated pa- 
tients. Since two-thirds of our patients were immuno- 
compromised, it is not intelligible why the diagnostic 
criteria for bacterial pneumonia, i.e. the amount of bac- 
terial burden in the lung to cause invasive infection, 
should not apply to patients with other types of host 
defense impairment, such as mechanical ventilation in 
an ICU setting. 
We are well aware that our study lacks a gold standard 
for the diagnosis of bacterial pneumonia. However, 
while the clinical diagnosis of bacteria1 pneumonia re- 
mains unreliable, especially in cases of nosocomiaI 
pneumonia [1, 23], we are confident hat none of the 17 
patients listed in Table 1 had bacterial pneumonia. In 
most cases the chest radiograph was normal or showed 
only slightly increased interstitial markings, and in all 
cases another diagnosis could be established. It was not 
our intention to demonstrate he value of BAL for the 
diagnosis of pneumonia but to prove the low specificity, 
i.e. the high number of false~positive r sults, using the 
methodology of the BI. Therefore, we decided to study 
a consecutive heterogenous series of patients with a low 
prevalence of pneumonia, including ventilated and 
83 
nonventilated as well as immunocompromised and im- 
munocompetent patients. 
Our findings of a low specificity of the BI are supported 
by a recent paper investigating 27 mechanically venti- 
lated patients without clinical or radiographic evidence 
of pulmonary infection [24]. Analyzing the BAL  data 
by means of the BI at a cut-off of 6 gave 23% false- 
positive results. The authors suggest that a BI of 8 
would be the best threshold to get a low percentage of 
false-positive results. This value is far higher than the 
BI cut-off of 5 or greater used by most other authors 
Is, 91. 
In contrast o the BI, the use of the absolute number of 
cfu/ml BAL fluid of the individual organisms at the cut- 
off point of 105 was highly specific (99%) for the diag- 
nosis of bacterial pneumonia. On the other hand, the 
relatively low sensitivity (33%) of the cfu/ml BAL  fluid 
was mainly due to a high rate of patients receiving an- 
timicrobial therapy prior to bronchoscopy. This is a ma- 
jor problem in the use of quantitative cultures in clini- 
cal practice and has been addressed by others [22]. 
Considering merely the cases not treated with antibio- 
tics prior to BAL, the sensitivity for the diagnosis of 
bacterial pneumonia increased to 70%, which is com- 
parable to the findings of other studies [16]. This is also 
clearly demonstrated by the large increase of the AUC 
in the ROC analysis (Figure 2). As mentioned above, 
however, it must be remembered that this study was 
not designed to assess the value of BAL  for the diagno- 
sis of bacterial pneumonia, and that there was no gold 
standard test to prove the true-positive rate, i.e. the 
sensitivity of the BAL  cultures. 
In conclusion, we have shown that the use of the BI as 
a diagnostic parameter for bacterial pneumonia results 
in an unacceptably ow specificity. Thus, the concept of 
the BI is not applicable to clinical practice. Quantitative 
bacterial cultures of BAL  fluid, however, may be a val- 
uable tool for the diagnosis of bacterial pneumonia 
when the absolute amount of colony-forming units of 
individual species per milliliter of BAL  fluid is used at 
a cut-off point of 10 5, especially when patients without 
prior antibiotics are considered. 
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